Kura Oncology Inc (FRA:KUR)
€ 18.41 -0.035 (-0.19%) Market Cap: 1.41 Bil Enterprise Value: 938.19 Mil PE Ratio: 0 PB Ratio: 3.02 GF Score: 36/100

Kura Oncology Inc Investor Day Transcript

Jun 12, 2023 / 12:00PM GMT
Release Date Price: €12.1 (-3.97%)
Troy Edward Wilson;
Kura Oncology, Inc. - Chairman, CEO & President

Good morning, everyone, and welcome to Kura's 2023 EHA Investor Event. I'm Troy Wilson, Kura's President and CEO. And I have the pleasure of having a number of our speakers here today who will introduce themselves.

If we can go to Slide #2. I just want to remind everyone that today we're going to be making forward-looking statements. And I would refer you to our website or to the SEC website for more information about the risks and uncertainties of an investment in Kura Oncology.

If we go to the next slide. So here's the agenda for our call. We're going to start with welcome and opening remarks. Then Stephen is going to introduce our investigators. We're going to give both Dr. Issa and Dr. Fathi, an opportunity to walk through the data. And then we'll do a Q&A session with both Dr. Issa and Fathi as well as our team, Stephen Dale and Mollie Leoni.

And with that, I'm going to -- we'll go to the next slide, and I'll turn it over to -- Slide #4, and I'll turn it over to Dr. Stephen Dale.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot